Neuro-Inclusive Employers
Explore companies that are tapping into neurodivergent talent as a strategic advantage. These forward-thinking organizations have established dedicated programs for recruiting and supporting employees with autism, ADHD, and other forms of neurodivergence, potentially driving innovation and long-term growth.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
Companies embracing cognitive diversity gain access to unique perspectives and talents that can spark innovation. These organizations recognize that neurodivergent individuals often possess exceptional pattern recognition, problem-solving abilities, and attention to detail that create genuine competitive advantages in today's knowledge economy.
What You Need to Know
This collection spans diverse sectors including tech, finance, healthcare, and manufacturing. What unites them is their formal commitment to neurodiversity through established programs like "Autism at Work" initiatives. These aren't just social responsibility efforts—they're strategic talent acquisition approaches that can impact bottom-line performance.
Why These Stocks
Each company in this collection has been carefully selected based on having formal, large-scale programs specifically designed for recruiting and supporting neurodivergent talent. These aren't token efforts, but substantial initiatives that demonstrate these companies' understanding that diverse thinking drives innovation and creates long-term shareholder value.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+13.19%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 13.19% over the next year.
Stocks Rated Buy by Analysts
11 of 15 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
The Untapped Talent Edge
Companies on this list are accessing exceptional skills that others miss. By embracing neurodivergent perspectives, they're gaining unique problem-solving advantages that could translate to market leadership.
DEI's New Frontier
Investors and customers increasingly reward meaningful diversity initiatives. These companies are ahead of the curve with substantive neurodiversity programs that go beyond tokenism to create genuine value.
Tomorrow's Workplace Today
As the competition for talent intensifies, these forward-thinking companies are building inclusive cultures that attract top performers across neurotypes. They're positioning for workforce advantages that could drive long-term growth.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.